Clinical Trials Logo

Allodynia clinical trials

View clinical trials related to Allodynia.

Filter by:

NCT ID: NCT01435798 Completed - Spinal Cord Injury Clinical Trials

Clinical Neuropharmacology of Pain in Spinal Cord Injury

Start date: August 2000
Phase: Phase 2
Study type: Interventional

This study is an NIH-funded two-part clinical trial to determine the best dose-ratio of individual subjects with central neuropathic pain following spinal cord injury (SCI), when two compounds with different target mechanisms are administered as combination therapy. The investigators will first determine each subjects' maximally tolerated dose (MTD) of chronic oral (PO) administration of dextromethorphan (Dex); the investigators will then randomize subjects to receive multiple dose-combinations of dextromethorphan and lidocaine (Lido). The investigators will be able to determine each subject's individual dose-response relationship for the separate compounds with adequate power, and thus also confirm the analgesic efficacy of high dose dextromethorphan and lidocaine, each in central neuropathic pain.

NCT ID: NCT01357798 Completed - Headache Clinical Trials

Botulinum Toxin Type A in Treatment of Cranial Allodynia in Patients With Headache

Start date: December 2010
Phase: Phase 3
Study type: Interventional

The objective of this study is evaluated if the Botulinum Toxin Type A is superior to 0,9% saline in treatment of cranial Allodynia in patients with headache. Hypothesis H(0): Botulinum Toxin Type A is not superior to 0,9% saline in treatment of cranial Allodynia in patients with headache H (1): Botulinum Toxin Type A is superior to 0,9% saline in treatment of cranial Allodynia in patients with headache